Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study

por Poewe, Werner, Volc, Dieter, Seppi, Klaus, Medori, Rossella, Lührs, Petra, Kutzelnigg, Alexandra, Djamshidian, Atbin, Thun-Hohenstein, Caroline, Meissner, Wassilios G., Rascol, Olivier, Schneeberger, Achim, Staffler, Günther, Poewe, Werner, Seppi, Klaus, Djamshidian, Atbin, deMarzi, Roberto, Heim, Beatrice, Mangesius, Stephanie, Stolz, Raphaela, Wachowicz, Katarzyna, Volc, Dieter, Thun-Hohenstein, Caroline, Riha, Constanze, Schneeberger, Achim, Bürger, Vera, Galabova, Gergana
Publicado 2021